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Objective: This study was done to determine the potential benefits of 
minimally invasive mitral surgery performed with intraoperative video 
assistance. Methods: From May 1996 until March 1997, a minithoracotomy 
and video assistance were used in 31 consecutive patients undergoing 
mitral repair (n = 20) and replacement (n = 11). Their ages ranged from 
18 to 77 years (59 - 2.6 years; mean - standard error of the mean). 
Ejection fractions were 35% to 62% (55% - 1.5%). Operations were done 
with either antegrade/retrograde (n = 10) or antegrade (n = 19) cold blood 
cardioplegia nd a new transthoracic rossclamp or with ventricular 
fibrillation (n = 2). Peripheral arterial cannulation (n = 28) and pump- 
assisted right atrial drainage (n = 26) were used most often. Results: No 
hospital deaths occurred, but the 30-day mortality was 3.2%. Complications 
included deep venous thrombosis and a phrenic nerve palsy in one patient 
each. No patient had a stroke or required reoperation for bleeding. 
Postoperative echocardiography showed excellent valve function in all but 
one patient. Cardiopulmonary b pass and arrest imes averaged 183 + 7.2 
and 136 +- 5.5 minutes, respectively. Compared with 100 patients having 
conventional mitral valve operations, these patients had significantly 
shorter hospitalization times (8.6 _ 0.5 vs 5.1 + 0.9 days, p = 0.05). 
Moreover, 81% of the later cohort were discharged between day 3 and 5 
(3.6 - 0.2 days). Hospital charges( $27%,p = 0.05) and costs ( $ 34%,p < 
0.05) were less than in conventional operations. Patient follow-up suggested 
minimal perioperative pain and rapid recovery. Conclusions: Early results 
suggest hat video-assisted minimally invasive mitral operations can be 
done safely. These methods may benefit patients through less morbidity, 
earlier discharge, and lower cost. (J Thorac Cardiovasc Surg 1997;114:773-82) 
M inimally invasive cardiac surgery may offer ben- efits over conventional sternotomy-based pro- 
cedures. Recently, minimally invasive coronary by- 
pass operations performed on the beating heart 
have been shown efficacious, especially in patients 
with left anterior descending coronary disease. 1-3 
Also, multivessel coronary operations, with intralu- 
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minal aortic balloon occlusion and cardioplegia, is 
being evaluated with great interest. 4'5 Minimally 
invasive valve operations also have been performed 
through various incisions and may prove even more 
promising than coronary grafting, because detailed 
vascular anastomoses are not required. 6-1° Despite 
widespread enthusiasm for these alternative opera- 
tive approaches, caution has been emphasized, in- 
asmuch as traditional coronary and valve operations 
have shown long-term success with ever-decreasing 
morbidity and mortality. It' 12 Thus comparative op- 
erative safety, speed of recovery, discomfort, and 
cost, as well as long-term operative quality, remain 
important end points when these new procedures 
are evaluated. 
Methods 
In this study, 31 consecutive patients undergoing video- 
assisted minimally invasive mitral valve surgery (VMIMS) 
by one surgeon at East Carolina University, between May 
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Fig. 1. The patient is positioned with the right side of the 
chest elevated 30 to 45 degrees. The incision is placed in 
the inframammary fold over the fifth rib. The cephalad X
mark indicates the insertion site for the transthoracic 
crossclamp and the caudal mark indicates the port-site for 
the thoracoscope. External defibrillator pads should be 
applied. 
1996 and March 1997, were evaluated retrospectively. For 
comparison, the previous 100 standard mitral operations, 
done by the same surgeon between January of 1992 and 
1997, were analyzed retrospectively. The operating sur- 
geon obtained informed consent after a detailed discus- 
sion of potential complications with the patient and 
family. All patients with isolated mitral disease, who were 
referred after May 1996, were offered a minimally invasive 
operation: however, two patients opted for a sternotomy 
and are included in the conventional group. Patients 
requiring concomitant coronary artery bypass grafting 
were excluded from both cohorts. Statistical comparisons 
for all data were made with the use of a 2( 2 analysis to 
calculate significance with respect o discrete variables. 
Operative and postoperative times were compared by 
means of a two-tailed t test. Data are shown as -+ standard 
error of the mean. 
Our operative approach for VMIMS has been de- 
scribed previously. 13'14 Patients were intubated for 
single left lung ventilation to facilitate atrial cannula- 
tion. For hemodynamic monitoring, a flow-directed 
pulmonary artery catheter was inserted through a right 
internal jugular vein introducer. External defibrillator 
pads were placed for postarrest cardioversion. An 
Omniplane transesophageal echocardiographic probe 
(Hewlett-Packard, Inc., Andover, Mass.) was posi- 
tioned for preoperative, intraoperative, and postopera- 
Fig. 2. A segment of the fourth rib anteriorly is removed. 
The transthoracic crossclamp is passed through the third 
intercostal space, in front of the superior vena cava, and 
through the transverse sinus to occlude the ascending 
aorta just caudal to the right pulmonary artery. Antegrade 
cardioplegia nd aortic venting is provided by a video- 
scopically placed needle in the ascending aorta. The 5 mm 
telescope and thoracoscopic camera are shown inserted 
through aport in the fourth intercostal space. The camera 
port intercostal space is not selected until the superior 
pulmonary vein is identified. 
tive studies that assessed ventricular function, intracar- 
diac air removal, and procedural quality. 
A measured 6 cm right anterolateral, inframammary 
incision was made and the thorax entered through the bed 
of a resected fourth rib segment, which obviated the need 
for rib spreading (Figs. 1 and 2). Modifications of standard 
perfusion and myocardial protection techniques were 
used throughout. In five early patients (16%), both the 
femoral artery and vein were cannulated for arterial 
inflow and pump-assisted venous drainage. Direct atrial 
centrifugal pump-assisted drainage with a 23F Bio-Medi- 
cus venous cannula (Medtronic Bio-Medicus, Eden Prai- 
rie, Minn.) was used in 26 patients (84%). In 28 opera- 
tions (90%), femoral arterial inflow was established with 
the use of a flexible 17F Bio-Medicus cannula inserted 
over a guide wire by the Seldinger technique. Either a 
diminutive femoral artery or aortoiliac occlusion ecessi- 
tated transthoracic, direct aortic arch cannulation i  three 
patients. 
Cardiac arrest was induced by means of a newly de- 
signed transthoracic aortic Crossclamp (Scanlan Interna- 
tional, Inc., Minneapolis, Minn.) inserted through a 4 mm 
incision in the third intercostal space (Fig. 3). 13' 14 In 10 
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Fig. 3. The transthoracic crossclamp is shown in two pincer-tip lengths. The clamp mechanism works 
completely within the thorax (Scanlan International, Minneapolis, Minn.). 
early patients (32%), retrograde cold blood cardioplegia 
was used in combination with antegrade administration. 
However, in 19 patients (61%), cold blood cardioplegic 
solution was given directly, and nearly continuously, 
through an aortic root catheter with potassium concentra- 
tions varied to maintain complete arrest. This catheter 
served as an aortic vent for air after crossclamp removal. 
Two operations (7%) were done with the use of cold 
ventricular fibrillation. Systemic ardiopulmonary perfu- 
sion was maintained between 26 ° and 28°C throughout 
both arrest and fibrillatory periods. 
Either a 5 or 10 mm thoracoscope (0-degree or 
30-degree view), connected to a three-chip Linvatec 
camera (Linvatec, Inc., Largo, Fla.), was inserted 
through a port placed through the fourth or fifth 
intercostal space (Figs. 1 and 2). Most frequently, a 5 
mm telescope was passed into the heart through a 3 to 
4 cm left atriotomy, made just anterior to the superior 
pulmonary vein. In many cases the 30-degree view 
telescope overcame limitations inherent in two-dimen- 
sional visualization and facilitated intracardiac instru- 
ment manipulation. Most of each operation, including 
crossclamp lacement, valve inspection, annular suture 
placement, chord replacement, and knot tying, was 
directed by thoracoscopic secondary vision. Posterior 
leaflet repairs and atriotomy closure often were done by 
direct vision, enhanced by long focal-distance loupes 
(3.5 ×). Newly developed instruments (Scanlan Interna- 
tional) provided retraction, valve tissue excision, knot 
tying, and suture cutting. For valve replacements, we 
used the St. Jude Medical mechanical prosthesis (St. 
Jude Medical, Inc., St. Paul, Minn.) with the posterior 
valvular-chordal pparatus always preserved. For valve 
replacements, 2-0 pledget-supported Ti-Cron sutures 
(Davis & Geck, Inc., Danbury, Conn.) were used. 
Annuloplasties were performed with the use of either a 
Carpentier-Edwards Physio ring or the Cosgrove-Edwards 
band (Edwards CVS Division, Baxter Healthcare Corp., 
Irvine, Calif.) with 3-0 nonpledget-supported Ti-Cron 
annular sutures. 
Results 
Table I provides demographic data for patients in 
both the VMIMS and conventional sternotomy 
groups. Cohorts were similar for age, sex, and 
functional class. Despite a consecutive series, pa- 
tients undergoing VMIMS had statistically better 
ventricular function. Eleven patients having mini- 
mally invasive procedures (35%) underwent mitral 
valve replacement, and 20 (65%) had a repair. Two 
patients undergoing valve replacement had degen- 
erative disease and nine had rheumatic involvement. 
Valve diseases in patients having valve repair by 
VMIMS were similar to those in patients having 
sternotomy repairs and included degenerative dis- 
ease (n = 12), annular dilatation (n = 4), rheumatic 
disease (n = 2), and healed endocarditis (n = 2). 
Operative techniques used for both groups are listed 
in Table II. No patients in the VMIMS group 
required a larger incision or a sternotomy, and no 
repairs resulted in a secondary replacement. 
Table III relates perioperative clinical data for 
both groups. No hospital deaths occurred in the 
VMIMS group. However, one patient in New York 
Heart Association class I died suddenly 27 days after 
discharge of a presumed ventricular arrhythmia 
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Table I. Demographic data 
Conventional 
VMIMS sternotomy 
(n : 31) (n = 100) 
Age (yr) 
Mean 59 _+ 2.6 59.3 -- 1.4 
Range 18-77 29-78 
Sex 
Men 12 (39%) 47 (47%) 
Women 19 (61%) 53 (53%) 
Preop. functional class 
(NYHA) 
Class I 1 (3%) 8 (8%) 
Class II 13 (42%) 42 (42%) 
Class III 14 (45%) 40 (40%) 
Class IV 3 (10%) 10 (10%) 
Ejection fraction (%) 
>40% 29 (93%) 63 (63%)* 
<40% 2 (6%) 37 (37%)* 
NYHA, New York Heart Association. 
*p = 0.001. 
(30-day mortality = 3.2%). Autopsy revealed no de- 
monstrable disease and normal prosthesis function. 
Comparatively, the 30-day mortality for patients hav- 
ing conventional sternotomy was 2.2% (p = not sig- 
nificant). One late death occurred at 3 months and was 
related to prosthetic valve endocarditis. 
Cardiopulmonary perfusion and aortic cross- 
clamp times averaged 183 _+ 7.2 and 136 _+ 5.7 
minutes, respectively. No aortic clamp injuries oc- 
curred, and no difficulties were encountered in 
weaning patients from bypass. In several patients, 
the immediate postarrest electrocardiogram showed 
inferior lead changes, despite meticulous cardiac 
deairing. Others have noted similar alterations. 15
However, the changes were transient and did not 
result in ventricular dysfunction, complex arrhyth- 
mias, or an infarction. By transesophageal chocar- 
diography, postoperative ventricular function was 
qualitatively similar to each preoperative study. One 
patient who underwent VMIMS repair had a mod- 
erate residual leak but remains free of symptoms 10 
months later. 
As seen in Table III, both ventilatory and inten- 
sive care unit times tended to be lower than in 
conventional operations. Patients in the VMIMS 
group were extubated 12.1 + 1.6 hours after the 
operation and were transferred from the intensive 
care unit 28.8 +_ 7.2 hours after the operation. For 
the 97% of patients in the VMIMS group (n = 30) 
requiring 48 hours or less of ventilatory support, the 
overall stay in the intensive care unit was signifi- 
cantly less than for the sternotomy group (p = 0.05). 
Table II. Operative t chniques 
Conventional 
VMIMS sternotomy 
Operative technique (n = 31) (n = 100) 
Valve replacement 11 (35%) 43 (43%) 
Valve repair 20 (65%) 57 (57%) 
Annuloplasty alone 8 (40%) 27 (47%) 
Annuloplasty--quad resection 10 (50%) 17 (30%) 
Annuloplasty--chordal replacement 2 (10%) 5 (9%) 
Annuloplasty--chordal transfer 0 (0%) 8 (14%) 
Overall, patients in the VMIMS group had a 5.1 _+ 
0.9 day hospital stay, with 81% being discharged 
between the third and fifth postoperative days (p = 
0.001). In the last half of the series, the length of 
hospitalization fell to 3.6 + 0.3 days. In both series 
a similar incidence (20%) of new atrial fibrillation 
occurred in the postoperative p riod. 
Operative complications for both groups are 
shown in Table IV. Major complications for the 
VMIMS group included deep venous thrombosis 
and a phrenic nerve palsy. The latter patient was 
supported with a ventilator for 17 days, representing 
the only individual requiring respiratory support for 
more than 48 hours. While in the intensive care unit, 
two patients required insertion of a bronchoscope 
to reexpand a right upper lobe that had collapsed 
as a result of endotracheal tube occlusion. In the 
VMIMS group there were no neurologic deficits 
or reexplorations for bleeding. By comparison, in 
the conventional sternotomy group 4% required 
reexplorations for bleeding and 3% had a tran- 
sient stroke (p = 0.05). Transfusion volumes of 
packed red cells and frozen plasma were less than 
in the sternotomy group (p = 0.05). However, 
38% of patients in the VMIMS group still re- 
ceived blood product ransfusions. 
Follow-up for patients undergoing VMIMS was 
100% by visit and telephone call, averaging 23.6 _+ 
2.5 weeks (5 to 47 weeks). Although no quantitative 
indices of discomfort or activity were measured, 
these patients reported little to no perioperative 
pain, with rapid return to normal activities. With the 
exception of the patients with deep venous throm- 
bosis and phrenic nerve palsy, all patients who had 
had VMIMS were allowed to return to normal 
activities 2weeks after discharge. Of the group, 48% 
improved by one functional class, 41% improved by 
two, and 7% improved by three functional classes 
after the operation. At follow-up 93% of patients in 
the VMIMS group were in functional class I or II. 
To evaluate conomic implications, we compared 
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Table IIL Perioperative data 
Conventional 
VMIMS sternotomy 
Crossclamp time (rain) 136 +- 5.5 92 _+ 3.6* 
Pump time (rain) 183 _+ 7.2 116 _+ 4.4* 
PRBC infused (units) 2.1 _+ 0.2 3.6 +_ OAt 
Hospital stay (days) 5.1 _+ 0.9 8.6 _+ 0.5* 
ICU stay: If ventilated <48 hr (hr) 22.3 _+ 2.9 48.7 _+ 8.2t 
ICU stay: Total group (hr) 28.8 + 7.2 48.7 _+ 8.2 
Ventilator period (hr) 12.1 _+ 1.6 22.7 _+ 5.2 
Chest tube drainage (ml) 623 _+ 99 716 _+ 86 
Patients transfused 38 50 
Atrial fibrillation (%) 
Preoperative 49 48 
Postoperative 78 73 
New postoperative 20 20 
PRBC, Packed red blood cells; ICU, intensive care 
*p = 0.001. 
tp = 0.05. 
unit. 
hospital charge and cost data for the two groups 
(Table V). After cost adjustments for the valve or 
annuloplasty prosthesis, both charges and costs were 
found to be 27% and 34% less, respectively, for the 
VMIMS than for the conventional sternotomy 
group (p = 0.02). Charge and cost reductions re- 
sulted primarily from the reduced length of stay. 
Overall, time in the operating room for minimally 
invasive operations was approximately 1.6 hours 
longer than for conventional operations. At our 
hospital, operating room charges till remain proce- 
dure-based, masking potential time-dependent cost 
variances. Both operative groups were treated by 
the same critical care pathway; thus cost variations 
appeared unrelated to temporal changes in our 
protocol. 
Discussion 
Minimally invasive mitral valve surgery may offer 
advantages over operations done through conven- 
tional sternotomy incisions. Recent animal studies 
suggest hat excellent myocardial preservation can 
be provided in near-closed chest models by means 
of intraaortic balloon occlusion and antegrade car- 
dioplegia. 15 In early 1996, using a similar technique 
(Heartport, Redwood City, Calif.) and a minithora- 
cotomy, the Stanford group performed four mini- 
mally invasive mitral valve replacements in pa- 
tients. 1° Recently, the group from the University of 
Leipzig reported on 24 patients with mitral valve 
disease who were operated on successfully by means 
of the same technique. 16By May 1997, this balloon 
occlusive device had been used for mitral valve 
Table IV. Operative complications 
Conventional 
VMIMS sternotomy 
Transient neurologic (%) 0 3.0 
Delirium (%) 0 3.0 
Transient neuropathy (%) 3.2 0 
Bleeding: Reexploration (%) 0 4.0 
Heart block: Pacer (%) 0 2.0 
Gastrointestinal (%) 3.2 2.0 
Pneumonia (%) 0 3.0 
Renal insufficiency (%) 0 1.0 
Deep venous thrombosis (%) 3.2 0 
Phrenic nerve palsy (%) 3.2 0 
operations in 252 patients worldwide, with a 6.3% 
mortality. Others have shown that parasternal, 
transsternal, and hemisternotomy incisions may be 
used with direct aortic clamping. 6-8 Recently, Cos- 
grove, Sabik, and Navia 7 described 49 mitral oper- 
ations performed through a small right parasternal 
incision with excellent results. 
To achieve the potential benefits of VMIMS, we 
applied modifications of conventional operative 
technology, including (1) the minithoracotomy, 
(2) percutaneous transthoracic aortic occlusion, 
(3) video assistance, (4) centrifugal pump-assisted 
venous return, and (5) peripheral arterial perfu- 
sion. As noted by others, the parasternal and 
hemisternotomy approaches offer excellent intra- 
cardiac exposure; however, larger cardiac inci- 
sions are needed. Valve exposure may require 
division of the left atrial roof, interatrial septum, 
and sinoatrial nodal artery with possible early 
junctional arrhythmias. With the parasternal ap- 
proach, an anterior chest wall defect results if 
costal cartilages are removed. The minithora- 
cotomy is familiar, obviating these concerns, and 
offers excellent mitral exposure, especially when 
combined with video assistance. Recently, several 
authors have reiterated the merits of this surgical 
approach in congenital and valve surgery. 18-22 
Thus application to minimally invasive valve sur- 
gery seems ideal, because the anterolateral inci- 
sion provides a direct, perpendicular view of the 
mitral orifice with minimal operative pain. 
Transthoracic aortic clamp occlusion was not dif- 
ficult and antegrade cardioplegia provided excellent 
cardiac protection. 13' 14 Video assistance was used to 
guide passage of the clamp through the transverse 
sinus and to occlude the aorta. No aortic clamp 
occlusion injuries resulted in these patients. To 
avoid injury to the right pulmonary artery and left 
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Table V. Hospital charges versus cost 
Hospital charges Hospital costs 
per patient per patient 
Conventional sternotomy (n = 100) 
VMIMS (n = 31) 
Mean difference in dollars 
Difference in percent 
$42,413 + $2,594 $27,049 -+ $1,909 
$30,985 -+ $2,408 $17,884 -+ $1,700 
$11,428" ,I $9,165" 
27% 1, 34% 
p < 0.02. 
atrial appendage, we were careful along the poste- 
rior aorta. With VMIMS, ventral eft atrial retrac- 
tion displaces the aorta less than in sternotomy 
operations, usually maintaining aortic valve compe- 
tence with an air-free aortic root. This made near 
continuous antegrade cardioplegia possible. The 
endovascular ortic clamp (Endoaortic Clamp, de- 
veloped by Heartport, Inc., Redwood City, Calif.) 
provides intraluminal aortic occlusion and ante- 
grade cardioplegia capabilities. However, balloon 
catheter insertion may have a higher potential for 
aortic dissection than direct occlusion. Moreover, in 
smaller patients and those with significant aortoiliac 
occlusive disease, passage of an intraaortic atheter 
may be impossible. In addition, proximal balloon 
migration could cause innominate artery occlusion, 
rendering untoward neurologic complications. At 
present, intraaortic occlusive balloons add signifi- 
cant supply costs ($5000) and precise positioning of 
the ascending aorta requires personnel support. For 
mitral valve operations, the percutaneous transtho- 
racic clamp appears afe and requires no additional 
resources. 
Cardiac surgery is the last specialty to use the 
benefits afforded by video assistance. To date, most 
port-access and sternal modification, or parasternal, 
valve operations have been done with the use of 
direct vision. The benefits of operative videoscopy 
are being recognized gradually by cardiac surgeons 
world-wide. Video assistance has been helpful for 
closed-chest internal thoracic artery harvests and 
closure of the ductus arteriosus. 1-3'23 Recently, 
24 Kaneko and associates reported videoscopic assis- 
tance in mitral valve surgery done through an open 
sternotomy. In early 1996, Carpentier and cowork- 
ers 25 reported the first video-assisted mitral valve 
repair through a minithoracotomy using ventricular 
fibrillation. Three months later our group first per- 
formed a completely video-assisted mitral valve 
replacement through a minithoracotomy using the 
transthoracic aortic clamp and retrograde cardiople- 
gia. ~3 Others have reported atrial septal defect 
closures and mitral reoperations facilitated by video 
assistance.a7, 26,27 
In the 31 patients reported on in this study, video 
assistance was always helpful, and sometimes essen- 
tial, for providing optimal instrument access to many 
intracardiac sites. Tissue excision, suture placement, 
prosthetic valve/ring positioning, and knot tying all 
were facilitated by thoracoscopic vision. In most 
instances, we used a 0-degree telescopic amera; 
however, the 30-degree telescope was helpful for 
viewing commissures and fibrous trigones, as well as 
for minimizing instrument conflicts. In some circum- 
stances, had we not used video assistance, we would 
have had to enlarge the incision. Ventral left atrial 
retraction often was limited by the sternum, even 
when transthoracic retractors were used. In many 
circumstances, direct exposure of trigonal/commis- 
sural regions, the anterior anulus, and intracardiac 
papillary/chordal structures was difficult and visual- 
ization was enhanced through video assistance. Sec- 
ondary vision was most beneficial in large or obese 
patients, in those with a deep thorax, and in individ- 
uals with large left atria. Operative video dexterity 
clearly improved with experience. However, as 
Lytle ~1 has cautioned, the lack of three-dimensional 
perception still limits the full potential of this tech- 
nique. Three-dimensional intracardiac cameras, 
now in development, may facilitate even less-inva- 
sive mitral operations. 
Centrifugal pump-assisted, or suction, venous 
drainage worked well in this series. In nearly all 
VMIMS cases, arterial perfusion was established 
with a thin-walled femoral cannula inserted over a 
guide wire with the use of dilators. Although others 
have noted retrograde aortic dissections with mini- 
mally invasive coronary and mitral operations, no 
dissections occurred in this series. 16 However, with 
femoral arterial cannulation, the hazard of dissec- 
tion remains ever present, even with guide wire 
placement. Direct transthoracic aortic perfusion ap- 
pears to be our next major challenge to obviate this 
concern. At present, our preferred method for per- 
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forming minimally invasive mitral operations uses 
(1) a right minithoracotomy, (2)peripheral arterial 
perfusion, (3) central venous cannulation, (4) ante- 
grade aortic root cold blood cardioplegia, (5) trans- 
thoracic lamp aortic occlusion, (6) video assistance 
with a 5 mm telescopic amera, and (7) the use of 
specialized instruments. 
Despite the potential benefits of VMIMS, several 
concerns emanated from this early series and war- 
rant discussion. As in any retrospective study, com- 
parative shortcomings are inherent. However, if 
consecutive patient cohorts are compared, an over- 
all notion of the benefits and disadvantages of
VMIMS may be suggested. Although chest tube 
drainage in patients having minimally invasive pro- 
cedures was similar to that of patients having con- 
ventional sternotomy, overall transfusion require- 
ments and reexplorations for bleeding were less. 
Despite these benefits, blood product ransfusions 
still were given in 38% of the VMIMS group. This 
red cell requirement probably resulted from longer 
perfusion times, with attendant hemodilution, com- 
pared with the sternotomy group. Ideally, use of 
packed red cells will decrease with greater operative 
experience and shorter cardiopulmonary bypass 
times. 
The decision to repair a mitral valve should not be 
driven by the operative approach, but rather by the 
abnormality of the valve and the surgeon's ability. 11 
The quality of the final result should never be 
compromised to minimize hospital cost, improve 
cosmesis, or lessen temporary discomfort. Sixty-five 
percent of patients in the VMIMS group had valve 
repair, compared with 57% in the conventional 
cohort. Others also have shown a predominance of 
repairs done through minimal incisions. 13 Follow-up 
times remain short; however, postoperative trans- 
esophageal echocardiographic studies suggested 
similar repair quality in both groups. To attain 
VMIMS results that are similar to results achieved 
with conventional mitral replacements and repairs, 
the surgeon must have significant sternotomy-based 
experience before beginning videoscopic operations. 
Both "real-time" procedural economics and pa- 
tient satisfaction always remain difficult to assess. 
In this series, overall hospital charges and costs 
were reduced markedly for mitral operations done 
by this approach. However, these reductions ap- 
peared to result mainly from shorter stays in the 
intensive care unit and hospital. Longer operative 
times for the VMIMS group clearly elevated 
operating room costs compared with those of the 
patients having conventional sternotomy. How- 
ever, procedure-based operating room charges at 
our hospital make it difficult to calculate additive 
costs incurred by longer operations. Also, indica- 
tions of patient satisfaction, early return to work, 
and discomfort are particularly difficult to deter- 
mine retrospectively. In younger patients these 
could be major determinants for selection be- 
tween a sternotomy and a minimally invasive 
operation. Although the VMIMS group appeared 
to have less postoperative discomfort, a prospec- 
tive study, using appropriate psychometric mea- 
surements, is needed to clarify these issues. 
Our results suggest that VMIMS procedures are 
safe and may benefit patients through reduced in- 
tensive care unit stays, lower transfusion require- 
ments, less operative discomfort, earlier hospital 
discharge, and lower overall cost. Moreover, both 
mitral valve replacements and relatively complex 
repairs can be done by video-assisted methods with 
good operative results. Techniques used were mod- 
ified from current practices and have the benefit of 
not requiring added resources. Obviously, longer 
term follow-up will be necessary to determine ulti- 
mate clinical outcomes. The positive features of 
VMIMS can be challenged because of current in- 
creased operative times and greater technical chal- 
lenges. Broad experience with video assistance 
should diminish these concerns. 
A new era in cardiac surgery is evolving, and expo- 
sure through even smaller incisions will be the bridge 
to truly microinvasive heart operations. To perform 
these operations, "extracorporeal" surgeons will need 
intracavitary video depth perception, improved instru- 
ment stability, computer-directed motion, and perhaps 
tactile feedback. Rapid acquisition of video dexterity is
very important to those planning to be aboard for 
future minimally invasive operations. However, de- 
spite the advantages of developing technology invalve 
and coronary surgery, we must remain circumspect 
and cautious, remembering that long-term valve and 
graft function is the objective, not application of the 
technique. 
We acknowledge Mr. William Hodges for perfusion 
technology, Ms. Laura Meadows for data analysis, Mr. 
Joseph Campbell for editorial review, and Mr. Michael 
Dulude for illustrations. 
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Discussion 
Dr. Aubrey C. Galloway, Jr. (New York, N.Y.). I would 
like to thank Dr. Chitwood for presenting an innovative 
approach to an evolving new area of cardiac surgery. 
These new techniques have engendered a lot of interest. 
Dr. Chitwood, you performed 31 minimally invasive mitral 
operations with video assistance, using a right anterolat- 
eral thoracotomy incision. You demonstrated excellent 
results with what is apparently a safe and effective oper- 
ation. There are some questions that do need to be 
answered, however. Whenever we introduce new tech- 
niques, we need to determine the incremental risk to the 
patient compared with the benefit hat is achieved from 
the new procedure. I want to address several of these 
issues regarding your proposed new technique. 
First, what is the need for video assistance per se? I 
would like to compare your series with a recent series 
from our institution, in which we performed approxi- 
mately 100 minimally invasive valvular operations using 
the port-access system. We initially used a thoracoscope 
for visual imaging and found that it was not necessary. The 
Stanford group, in contrast, used the port-access system 
but used a more lateral incision, similar to yours, and they 
needed the vidoescope to visualize the valve well. We 
make our incision transversely in the fourth intercostal 
space, but more anterior and medial, and do not remove 
costal cartilage. We found that with the transthoracic 
septal cardiac retractor we can see both the anterior and 
the posterior leaflets well in all patients. Consequently, we 
abandoned the videoscope, because it added little benefit 
but was more cumbersome and prolonged the operating 
time. I note in your manuscript that you did only two 
anterior leaflet repairs and you suggested that one really 
only needs the videoscope for anterior leaflet procedures. 
Thus it appears there are relatively few cases in which you 
actually need this. Did use of the videoscopic techniques 
cause any problems or increase the level of difficulty? How 
much do you think the videoscope actually aids in per- 
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forming the operation? Do you find that it is worth the 
cost in terms of crossclamp time? It appears from your 
numbers that your crossclamp times are significantly 
longer than you might have achieved if you had not used 
videoscopic imaging for suturing. 
This brings up a second question. The ejection fractions 
were high in your patients treated by VMIMS. Only 3% to 
5% of these patients had an ejection fraction of less than 
40%, whereas 37% of your patients having conventional 
sternotomy had an ejection fraction of less than 40%. 
Because of the increased crossclamp time, did you exclude 
high-risk patients when using the minimally invasive tech- 
niques? Although you reported good return of cardiac 
function, do you think that the longer crossclamp times 
might lead to problems if you applied your technique to 
patients with low ejection fractions and pulmonary hyper- 
tension? 
The third question relates to deairing techniques. How 
did you deair? Your method seems to be successful, 
inasmuch as none of your patients had a stroke. You did 
report some ST segment changes when you undamped, 
which I presume were related to air in the aortic root. This 
is an important problem for minimally invasive mitral 
surgery because there is no access to the apex of the heart. 
Finally, what is the validity of comparing two different 
approaches in terms of hospital costs when the groups are 
so different? I do not think your groups were matched well 
enough to provide a valid comparison. We already know 
that the ejection fraction was significantly better in the less 
invasive group. Were the anesthetic protocols, the wean- 
ing protocols, and the postoperative care maps any differ- 
ent? We have seen article after article showing the impact 
of care maps and management protocols on lowering 
intensive care unit stay, hospital stay, and overall cost. If 
these management protocols were not identical, then the 
cost savings and hospital stay comparisons are not valid. 
Dr. Chitwood. I would like to offer my complements o
your group at New York University for doing such a good 
job with the port-access technique and for pioneering 
much of this valve work. I will respond to your four 
questions. 
First, the need for a videoscope. Initially we started 
doing these operations on the way to a final product hat, 
in time, would probably be totally video-assisted valve 
surgery. When early on we determined that the perfusion 
times were longer, we looked very critically at our patients 
to make sure that we were doing the ethically right thing 
and that the patients were doing as well as they would 
have with other mitral operations. When we determined that 
the patients were doing as well, we continued to use video 
assistance because we believe that many of these minimally 
invasive operations will be video assisted ultimately. 
I agree with you that a more medial incision can provide 
a more direct visualization. I have been able to develop 
video dexterity by using the camera and placing most of 
the sutures and doing the things that I mentioned. With- 
out question, chordal transfers and some of the quadran- 
gular resections are more difficult and take more time 
when total video assistance is used. I believe that three- 
dimensional video assistance is on the way, and this will 
provide the major venue for us to do most of these mitral 
valve operations in a video-assisted fashion. Thus I agree 
with all of your comments related to direct visualization. 
Clearly, if I can take a nice stitch with direct visualization, 
I do. I use 3.5 power loupes that are corrected for the focal 
distance used in the minimally invasive mitral valve oper- 
ations. 
Second, the ejection fractions in the VMIMS cohort 
were better than in the conventional sternotomy group. 
These were consecutive patients having isolated mitral 
valve operations, with no coronary artery operations. That 
was really the only difference in this series. We did not see 
new dysfunction in either group in the postoperative 
period. Again, there were no patients with coronary 
disease involved in either series. 
Air removal is a very important issue because the right 
coronary artery is clearly the closest vent provided. We did 
indeed encounter some ST segment changes in some of 
these patients. Generally these changes resolved after a 
period of reperfusion. We did not observe any right 
ventricular dysfunction. The method that I use involves an 
aortic root vent. We do not use a transventricular vent. 
We fill the ventricle meticulously, under echocardio- 
graphic control. We ventilate the lungs with the head 
positioned own and reclamp the aorta, letting the heart 
beat against he clamped aorta with the right coronary 
artery occluded with a sponge stick. Despite all that, we 
still could see a few bubbles, from time to time, going to 
the right coronary artery with ST segment changes ensu- 
ing. I think this is the reason that none of our patients had 
a stroke. The heart was beating against he clamp, evac- 
uating air into the aortic vent. I know that you use a 
similar technique with the occlusion balloon. 
Regarding the validity of the hospital ength of stay 
data, the two groups were operated on at two different 
points in time. However, our critical care pathways were 
the same. Very early on, we instituted critical care and 
anesthetic pathways. There is no question that transfusion 
requirements were different because of this time differ- 
ence. In this series, we had fewer transfusion require- 
ments with similar amounts of bleeding, which leads me to 
believe that we transfused more liberally in earlier days. 
Dr. Friedrich W. Mohr (Leipzig, Germany). Your tech- 
nique describes a very simple way to achieve a minimally 
invasive approach to the mitral valve. In our entire series 
of 80 patients treated by minimally invasive mitral valve 
operations, I tried your approach in eight patients. My 
concern always is how to safely place the aortic clamp 
through the port and how to control the posterior wall to 
prevent injury to the pulmonary artery. Could you please 
comment on that? 
Dr. Chitwood. Before addressing your question, I would 
like to acknowledge your work with the Heartport ech- 
nology. You certainly pioneered that work. 
I think the clamp can be very safely placed. It is a secure 
clamp, and I have not had difficulties with it. Clamping all 
is done with video assistance, again with the pulmonary 
artery visualized as the clamp is applied. We can insert a 
5 mm camera through the transverse sinus to be sure that 
no injury to the left atrial appendage or the right pulmo- 
nary artery occurs as the clamp comes behind the aorta so 
that the clamp is positioned completely under video 
assistance. I have found this quite helpful. I do look 
several times to make absolutely sure no injury is occur- 
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ring. As you would with a clamp through a sternotomy 
incision, I occlude the aorta very carefully, only with two 
or three clicks, but it all is done with video assistance. 
Dr. Alain F. Carpentier (Paris, France). I rise to con- 
gratulate Dr. Chitwood and also to say a word of caution. 
Starting as early as February 1996, our experience com- 
prises 22 complex mitral valve repairs with video-assisted 
minimally invasive techniques exploring different ap- 
proaches. Whatever the approach you choose, the in- 
creased technical difficulty must be underlined. We must 
realize that this is extremely difficult surgery that can 
become maximally invasive if not done with wisdom. 
The results presented by Dr. Chitwood confirm our own 
experience that a minimally invasive approach can be 
explored very carefully with no operative deaths, no 
idiopathic omplications, no suboptimal surgical result. 
I have only one question for Dr. Chitwood, who did not 
talk about a problem that has been disappointing for 
us--the pain that occurs after the approach through a 
sternotomy. We found that the patients complain more 
after thoracotomy, even minithoracotomy, as when using 
a ministernotomy, which is the approach we prefer today 
to avoid opening the pleural cavity and dividing the 
thoracic artery. How did you manage this problem? 
Dr. Chitwood. I have to give all credit for learning about 
mitral valve repair to Professor Carpentier and my trips to 
Paris. Also, the video-assisted i ea was not an original 
one, inasmuch as I spoke with you at last year's AATS 
meeting about your earlier video-assisted operations. We 
have continued to do some of the work that you started. 
Pain is a consideration, and objective data are diffi- 
cult to obtain. Surgeons cannot really say to patients, 
"You're not having any pain, are you? .... You've had a 
minimally invasive operation; you're not supposed to 
have any pain." True evaluation of pain is extremely 
difficult. I believe that when the costal cartilages are 
spread or resected, patients do have more pain. The 
patients in our series have not had a lot of pain, but we 
do not have a true measurement. These studies are yet 
to be done. We resect a segment of the bony rib, and 
our patients have not had a lot of pain. 
I have seen your technique with the ministernotomy. 
Having had a sternotomy myself, I am in a unique position 
to evaluate operative sternal pain somewhat objectively. I 
believe that the ministernotomy does provide very little 
pain. However, we need to compare these approaches in a 
randomized fashion using good indices of pain. Your 
technique through the ministernotomy is an excellent one 
and is certainly just as good as my technique, if not better. 
Dr. Norberto G. De Vega (Malaga, Spain). You offer us 
an alternative to median sternotomy for mitral valve 
operations to avoid long hospital stays and to provide a 
more cosmetic incision. We have been using such an 
alternative for the past 5 years. We offered our patients a
somewhat larger thoracotomy, just 12 cm, and through 
this incision we can do what we call 3N mitral surgery: no 
median sternotomy, no femoral cannulation, and no myo- 
cardial ischemia. We do all of our operations with hypo- 
thermic ventricular fibrillation. We can cannulate the 
ascending aorta every time, and we do not use median 
sternotomy. 
Just by adding 6 cm to your thoracotomy, ou could avoid 
all the complications you have with your technique. I do not 
really know whether merely avoiding 6 cm is worth all the 
complications, allthe things you need to think about mad do, 
and the potential complications you have. 
Dr. Chitwood. Clearly it is more difficult to do this 
operation with video assistance, but I think we are on a 
train to the new future. I believe in time we will be able to 
do most of these completely with video assistance. 
I do agree completely with you that we must get away 
from femoral arterial cannulation. I have used transverse 
aortic arch cannulation with the Seldinger technique in 
four patients. I believe that through ports and small 
incisions we can cannulate the aorta. However, it will be a 
while before we feel comfortable in doing this. I like your 
3N technique and believe that we can avoid femoral 
cannulation with our technique as well. 
